Temozolomide — Dosing in CKD & Dialysis
Temozolomide (Alkylating Agent): renal dosing adjustments, dialyzability (Removed by hemodialysis: mean dialyzer removal rate about 85% (pre- vs post-dialyzer plasma) in one patient (Tanaka 2023, PMID 37646650).), and renal-relevant safety risk for CKD and dialysis patients. Educational reference fo
Reviewed by Matt · November 16, 2026